B
BAX
BAXReviewed6 segments tracked|6 years of data|Annual (10-K)
Total Revenue
$4.4B15.6%
FY2024
Operating Segments
6Active segments
Blended Margin
79.2%Operating margin
Highest Margin
41.7%Medical Products And Therapies
Segment Shift
Medical Products And Therapies has grown from 0.0% to 52.2% of total revenue since FY2019, with 41.7% operating margins. Meanwhile, Healthcare Systems And Technologies is the fastest growing at +3.8% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Medical Products And Therapies | $2.3B | $950M | 41.7% | 52.2% | +2.3% |
| Healthcare Systems And Technologies | $1.3B | $468M | 35.7% | 30.0% | +3.8% |
| Pharmaceuticals | $780M | $313M | 40.1% | 17.8% | +2.8% |
| Reportable | $0 | $1.7B | 0.0% | 0.0% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free